These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 778617

  • 21. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J, Ozbay A, Tørring C, Hansen HE.
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [Abstract] [Full Text] [Related]

  • 22. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
    Lordon RE, Wilson RL, Shield CF, Ferrone S.
    Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
    [Abstract] [Full Text] [Related]

  • 23. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD, Van Breda Vriesman PJ.
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [Abstract] [Full Text] [Related]

  • 24. Anti-donor's B lymphocytes and anti-IgG antibodies in kidney allograft recipients: correlative study with the transplant outcome.
    de Mouzon A, Soulillou JP, Blanc M, Durand D, Ohayon E, Ducos J.
    Transplant Proc; 1979 Jun; 11(2):1267-8. PubMed ID: 382504
    [No Abstract] [Full Text] [Related]

  • 25. Mechanisms of allograft rejection.
    Hamburger J.
    Trans Am Soc Artif Intern Organs; 1976 Jun; 22():729-33. PubMed ID: 781987
    [No Abstract] [Full Text] [Related]

  • 26. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE, Levin VI, Buglova SE, Chashinskaia TI.
    Urol Nefrol (Mosk); 1984 Jun; (4):3-6. PubMed ID: 6382734
    [No Abstract] [Full Text] [Related]

  • 27. Occurrence and specificity of anti-B lymphocyte antibodies in renal allograft recipients.
    Fauchet R, Genetet B, Campion JP, Watelet J, Minet J, Cartier F, Launois B.
    Transplantation; 1980 Aug; 30(2):114-7. PubMed ID: 7010705
    [Abstract] [Full Text] [Related]

  • 28. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U.
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK, Robertson H, Carroll HP, Ali S, Kirby JA.
    Transplantation; 2003 Feb 27; 75(4):505-14. PubMed ID: 12605119
    [Abstract] [Full Text] [Related]

  • 31. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection.
    Davenport A, Younie ME, Parsons JE, Klouda PT.
    Nephrol Dial Transplant; 1994 Feb 27; 9(9):1315-9. PubMed ID: 7816298
    [Abstract] [Full Text] [Related]

  • 32. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M, Garovoy MR.
    Urol Clin North Am; 1983 May 27; 10(2):315-25. PubMed ID: 6222530
    [No Abstract] [Full Text] [Related]

  • 33. B-lymphocyte-specific antibodies in human renal allografts.
    Mohanakumar T, Giedlin M, DuVall C, Rhodes C, Phibbs M, Mendez G, Kaplan AM, Lee HM.
    Transplant Proc; 1979 Mar 27; 11(1):397-400. PubMed ID: 377664
    [No Abstract] [Full Text] [Related]

  • 34. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 35. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G, Mercuriali F, Scalamogna M, Rosso di San Secondo V, Pizzi C, Poli F, Fortis C, Greppi N.
    Transplant Proc; 1979 Mar 27; 11(1):950-3. PubMed ID: 377727
    [No Abstract] [Full Text] [Related]

  • 36. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
    Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS.
    N Engl J Med; 1981 Aug 06; 305(6):308-14. PubMed ID: 6454075
    [Abstract] [Full Text] [Related]

  • 37. Role of anti-donor B lymphocyte antibodies in definitive allograft rejection.
    Soulillou JP, de Mouzon A, Peyrat MA, Guenel J.
    Transplant Proc; 1979 Mar 06; 11(1):770-5. PubMed ID: 377710
    [No Abstract] [Full Text] [Related]

  • 38. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N, Shenoy S, Howard T, Flye MW, Mohanakumar T.
    Clin Transplant; 1997 Jun 06; 11(3):174-7. PubMed ID: 9193838
    [Abstract] [Full Text] [Related]

  • 39. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H, Otte B, Lang D, Heidenreich S.
    Clin Nephrol; 1996 Jan 06; 45(1):22-8. PubMed ID: 8616953
    [Abstract] [Full Text] [Related]

  • 40. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ, Naziruddin B, Oppat W, Flye MW, Mohanakumar T.
    Transplant Proc; 1995 Feb 06; 27(1):900-2. PubMed ID: 7879223
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.